| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 597,408 | 586,987 | 518,923 | 496,697 | | Cost of Revenue | 282,342 | 302,140 | 261,580 | 242,765 | | | Gross Profit | 315,066 | 284,847 | 257,343 | 253,932 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 187,626 | 199,700 | 176,163 | 164,929 | | Non Recurring | 1,554 | (3,581) | 768 | 579 | | Others | 99,621 | 89,733 | 76,609 | 86,033 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,265 | (1,005) | 3,803 | 2,391 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (25,714) | 882 | (718) | 5,233 | | Earnings Before Interest And Taxes | 1,066 | 1,356 | 2,994 | 6,588 | | Interest Expense | 49,060 | 41,851 | 49,149 | 45,352 | | Income Before Tax | (47,994) | (40,495) | (46,155) | (38,764) | | Income Tax Expense | 13,189 | 6,865 | 8,667 | 10,024 | | Minority Interest |
-
|
-
| (920) | (1,266) | | | | Net Income From Continuing Ops | (61,183) | (47,360) | (54,822) | (48,788) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (61,183) | (47,360) | (54,822) | (48,788) | | Preferred Stock And Other Adjustments | (1,568) | (2,936) |
-
|
-
| | | Net Income Applicable To Common Shares | ($62,751) | ($50,296) | ($54,822) | ($48,788) |
|
1.48% Nasdaq 
Income Statement
